Despite Federal and state legislative actions allowing the cultivation, sale and marketing of cannabis, regulatory and legal risks remain for the industry. What is the current state of play, and how is it evolving? Is it possible to market consumer goods containing CBD or other cannabinoids? What are the regulatory and litigation risks? What restrictions are there on financing cannabis businesses? How is COVID-19 impacting cannabis businesses? Our panel will guide you through the legal and regulatory thicket and will address the industry’s most pressing questions.
Chip Magid, Partner, Dorsey & Whitney LLP
Sativa Rasmussen, Associate, Dorsey & Whitney LLP
Joe Lynyak, Partner, Dorsey & Whitney LLP
Click here to view the materials from the webinar.
**NOTE: Watching this recording does not allow the user to obtain CLE, CPD, CPE or HR credits.